FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040181235> ?p ?o ?g. }

• W2040181235 endingPage "985" @default.
• W2040181235 startingPage "981" @default.
• W2040181235 abstract "Overweight or obesity has become a critical health problem in the world. The association of obesity with type 2 diabetes mellitus (T2D) has been recognized for decades, and the major basis for this link is the ability of obesity to engender insulin resistance (IR). Adipose tissue is not only an energy depot but also an active endocrine organ. Furthermore, fat distribution in the body is important for the progress of IR. Many studies show that visceral fat is more important in relation to IR than subcutaneous fat. Circulating free fatty acids (FFAs) derived from adipocytes are elevated in many IR states and have been suggested to be a main underlying mechanism of IR in obesity-associated T2D. However, compelling evidence demonstrates that adipocytokines including several adipocyte-derived cytokines or hormones are also involved in obesity-induced IR. Therefore, we hypothesise that adipocytokines may be a bridge connecting obesity and IR, and abnormal fat depot distribution or visceral fat/subcutaneous fat ratio (V/S ratio) in obesity also could be a primer for IR. When visceral fat accumulates and V/S ratio deteriorates , just like a primer,in visceral obesity it should begin to display unhealthy effect begin to take place in the body. In addition to it, as one of physiological regulation mechanisms of the body, most of the adipocytokines from the visceral fat reduce the visceral fat volume or normalize the V/S ratio. Actually, on the contrary, with serum a change in the serum adipocytokine level and an imbalance of them in the body for a long term, it will become a pathological condition and various kinds of effects may contribute to the development of IR. If confirmed, this hypothesis may lead to the formulation of new pathogenesis and new therapeutic approaches to IR. For example, an effective slimming pill will be assessed in future on the basis of the decrease of V/S and serum adipocytokines level rather than of body weight." @default.
• W2040181235 created "2016-06-24" @default.
• W2040181235 creator A5008668856 @default.
• W2040181235 creator A5055388661 @default.
• W2040181235 creator A5070273499 @default.
• W2040181235 creator A5082253187 @default.
• W2040181235 date "2009-12-01" @default.
• W2040181235 modified "2023-09-26" @default.
• W2040181235 title "Adipocytokines: A bridge connecting obesity and insulin resistance" @default.
• W2040181235 cites W146127655 @default.
• W2040181235 cites W1524321743 @default.
• W2040181235 cites W1965393911 @default.
• W2040181235 cites W1968251331 @default.
• W2040181235 cites W1980672646 @default.
• W2040181235 cites W2015237552 @default.
• W2040181235 cites W2018803560 @default.
• W2040181235 cites W2027279281 @default.
• W2040181235 cites W2028944015 @default.
• W2040181235 cites W2037446830 @default.
• W2040181235 cites W2041176514 @default.
• W2040181235 cites W2048970871 @default.
• W2040181235 cites W2049965571 @default.
• W2040181235 cites W2054800029 @default.
• W2040181235 cites W2056352776 @default.
• W2040181235 cites W2060899732 @default.
• W2040181235 cites W2067781349 @default.
• W2040181235 cites W2077745556 @default.
• W2040181235 cites W2082263940 @default.
• W2040181235 cites W2087433514 @default.
• W2040181235 cites W2091969401 @default.
• W2040181235 cites W2093394460 @default.
• W2040181235 cites W2094599609 @default.
• W2040181235 cites W2105506930 @default.
• W2040181235 cites W2106931189 @default.
• W2040181235 cites W2114510747 @default.
• W2040181235 cites W2124376410 @default.
• W2040181235 cites W2135110328 @default.
• W2040181235 cites W2147468118 @default.
• W2040181235 cites W2154132292 @default.
• W2040181235 cites W2159621813 @default.
• W2040181235 cites W2166449272 @default.
• W2040181235 cites W2166933182 @default.
• W2040181235 cites W2168519267 @default.
• W2040181235 cites W2169246660 @default.
• W2040181235 cites W2171835251 @default.
• W2040181235 cites W4231265096 @default.
• W2040181235 cites W4243810418 @default.
• W2040181235 cites W4244843963 @default.
• W2040181235 cites W4255297658 @default.
• W2040181235 doi "https://doi.org/10.1016/j.mehy.2009.05.036" @default.
• W2040181235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19692185" @default.
• W2040181235 hasPublicationYear "2009" @default.
• W2040181235 type Work @default.
• W2040181235 sameAs 2040181235 @default.
• W2040181235 citedByCount "37" @default.
• W2040181235 countsByYear W20401812352012 @default.
• W2040181235 countsByYear W20401812352013 @default.
• W2040181235 countsByYear W20401812352014 @default.
• W2040181235 countsByYear W20401812352015 @default.
• W2040181235 countsByYear W20401812352016 @default.
• W2040181235 countsByYear W20401812352017 @default.
• W2040181235 countsByYear W20401812352018 @default.
• W2040181235 countsByYear W20401812352019 @default.
• W2040181235 countsByYear W20401812352020 @default.
• W2040181235 countsByYear W20401812352021 @default.
• W2040181235 countsByYear W20401812352022 @default.
• W2040181235 countsByYear W20401812352023 @default.
• W2040181235 crossrefType "journal-article" @default.
• W2040181235 hasAuthorship W2040181235A5008668856 @default.
• W2040181235 hasAuthorship W2040181235A5055388661 @default.
• W2040181235 hasAuthorship W2040181235A5070273499 @default.
• W2040181235 hasAuthorship W2040181235A5082253187 @default.
• W2040181235 hasConcept C126322002 @default.
• W2040181235 hasConcept C134018914 @default.
• W2040181235 hasConcept C171089720 @default.
• W2040181235 hasConcept C194832188 @default.
• W2040181235 hasConcept C2776175234 @default.
• W2040181235 hasConcept C2777180221 @default.
• W2040181235 hasConcept C2777391703 @default.
• W2040181235 hasConcept C2780586474 @default.
• W2040181235 hasConcept C511355011 @default.
• W2040181235 hasConcept C555293320 @default.
• W2040181235 hasConcept C71924100 @default.
• W2040181235 hasConceptScore W2040181235C126322002 @default.
• W2040181235 hasConceptScore W2040181235C134018914 @default.
• W2040181235 hasConceptScore W2040181235C171089720 @default.
• W2040181235 hasConceptScore W2040181235C194832188 @default.
• W2040181235 hasConceptScore W2040181235C2776175234 @default.
• W2040181235 hasConceptScore W2040181235C2777180221 @default.
• W2040181235 hasConceptScore W2040181235C2777391703 @default.
• W2040181235 hasConceptScore W2040181235C2780586474 @default.
• W2040181235 hasConceptScore W2040181235C511355011 @default.
• W2040181235 hasConceptScore W2040181235C555293320 @default.
• W2040181235 hasConceptScore W2040181235C71924100 @default.
• W2040181235 hasIssue "6" @default.
• W2040181235 hasLocation W20401812351 @default.
• W2040181235 hasLocation W20401812352 @default.
• W2040181235 hasOpenAccess W2040181235 @default.

• next